InVivo halts trial of spine injury treatment after third patient dies – Boston Business Journal

Posted: Published on August 1st, 2017

This post was added by Dr Simmons


Boston Business Journal
InVivo halts trial of spine injury treatment after third patient dies
Boston Business Journal
InVivo (Nasdaq: NVIV) announced that it would temporarily stop enrolling patients in the trial of its Neuro-Spinal Scaffold, a biodegradable device invented in part by MIT professor Bob Langer designed to help patients heal after spinal cord injuries.
InVivo Therapeutics Announces Updates on the INSPIRE Study ...Business Wire (press release)
Invivo Therapeutics Holdings Corp - Receive News & Ratings DailyTheOlympiaReport
InVivo Therapeutics Holdings Corp. (NVIV) Plunges 5.56% on August 01Equities.com
Investing News Update -Highland Mirror
all 39 news articles »

Read the original post:
InVivo halts trial of spine injury treatment after third patient dies - Boston Business Journal

Related Posts
This entry was posted in Spinal Cord Injury Treatment. Bookmark the permalink.

Comments are closed.